Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10753-022-01715-z.

Title:
PCSK9 Promotes Endothelial Dysfunction During Sepsis Via the TLR4/MyD88/NF-κB and NLRP3 Pathways | Inflammation
Description:
Endothelial dysfunction often accompanies sepsis. We aimed to explore the role of PCSK9 in septic endothelial dysfunction. Sepsis was induced by lipopolysaccharide (LPS) treatment of human umbilical vein endothelial cells (HUVECs) in vitro and cecal ligation and puncture (CLP) surgery in mice in vivo. Evolocumab (EVC) and Pep 2–8, PCSK9 inhibitors, were subsequently used to determine the role of PCSK9 in sepsis-induced endothelial dysfunction in vitro and in vivo, respectively. In addition, the TLR4 agonist, Kdo2-Lipid A ammonium (KLA), was used to determine the related mechanism. Protein expression of eNOS, VE-cadherin, PCSK9, TLR4, MyD88, p-p65, p65, NLRP3, ASC, and caspase-1 p20 in mice aortas and HUVECs was measured by western blotting, while mRNA expression of TNFα, IL-1β, and IL-18 was determined by qRT-PCR. The level of inflammatory cytokines of mouse aortas was visualized by immunohistochemistry. Vasodilation of the aorta was detected by vascular reactivity experiments. The 96-h survival rate after CLP was assessed. Our findings showed that the expression of eNOS and VE-cadherin decreased, and PCSK9 expression increased, in septic HUVECs or mice. Inhibition of PCSK9 increased eNOS and VE-cadherin expression. Activation of the TLR4/MyD88/NF-κB and NLRP3 pathways may be responsible for PCSK9-induced endothelial dysfunction in sepsis. Vascular reactivity tests and survival studies showed that inhibition of PCSK9 could prevent the decrease in endothelium-dependent vasodilation function and improve the survival rates of septic mice. In summary, our results suggested that increased PCSK9 expression during sepsis activated the TLR4/MyD88/NF-κB and NLRP3 pathways to induce inflammation, which resulted in vascular endothelial dysfunction and decreased survival rates. Thus, inhibition of PCSK9 may be a potential clinical therapeutic target to improve vascular endothelial function in sepsis.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

pubmed, article, google, scholar, sepsis, cas, pcsk, endothelial, central, journal, dysfunction, research, inflammation, luo, septic, expression, vascular, medicine, nlrp, chongqing, early, authors, nature, shock, university, data, role, inhibition, zhang, hospital, medical, privacy, cookies, function, content, pathways, manuscript, huang, xia, mice, experiments, survival, access, wang, pathway, affiliated, springer, information, publish, search,

Topics {✒️}

month download article/chapter tlr4/nf-κb signaling pathway sirt3-ampk signaling pathway pcsk9-induced endothelial dysfunction tlr4/nf-κb pathway tlr4/nf-kb pathway sepsis-induced endothelial dysfunction clp-induced endothelial dysfunction tlr4/myd88/nf-κb improve lipopolysaccharide-induced mortality gorges central hospital full article pdf article inflammation aims endothelium-dependent vasodilation function vascular endothelial dysfunction septic endothelial dysfunction privacy choices/manage cookies inhibiting nf-κb reduces infarct size article huang activating endothelial α1ampk impaired cardiac repair newborn umbilical cord vascular lumen formation potential therapeutic target blood vessel formation nlrp3 signaling pathways investigación en arteriosclerosis endothelial dysfunction sepsis-induced cardiomyopathy european economic area pcsk9 expression increased increased pcsk9 expression nucleotide-binding domain pulmonary arterial hypertension van der poll pro-inflammatory cytokines ischaemia/reperfusion injury plasma pcsk9 levels pcsk9 modulates infection huazhi fugan granules national animal protection local ethical committee lipid-lowering effects yong xia conditions privacy policy vascular reactivity tests short-term survival acute heart failure chemico-biological interactions 305

Schema {🗺️}

WebPage:
      mainEntity:
         headline:PCSK9 Promotes Endothelial Dysfunction During Sepsis Via the TLR4/MyD88/NF-κB and NLRP3 Pathways
         description:Endothelial dysfunction often accompanies sepsis. We aimed to explore the role of PCSK9 in septic endothelial dysfunction. Sepsis was induced by lipopolysaccharide (LPS) treatment of human umbilical vein endothelial cells (HUVECs) in vitro and cecal ligation and puncture (CLP) surgery in mice in vivo. Evolocumab (EVC) and Pep 2–8, PCSK9 inhibitors, were subsequently used to determine the role of PCSK9 in sepsis-induced endothelial dysfunction in vitro and in vivo, respectively. In addition, the TLR4 agonist, Kdo2-Lipid A ammonium (KLA), was used to determine the related mechanism. Protein expression of eNOS, VE-cadherin, PCSK9, TLR4, MyD88, p-p65, p65, NLRP3, ASC, and caspase-1 p20 in mice aortas and HUVECs was measured by western blotting, while mRNA expression of TNFα, IL-1β, and IL-18 was determined by qRT-PCR. The level of inflammatory cytokines of mouse aortas was visualized by immunohistochemistry. Vasodilation of the aorta was detected by vascular reactivity experiments. The 96-h survival rate after CLP was assessed. Our findings showed that the expression of eNOS and VE-cadherin decreased, and PCSK9 expression increased, in septic HUVECs or mice. Inhibition of PCSK9 increased eNOS and VE-cadherin expression. Activation of the TLR4/MyD88/NF-κB and NLRP3 pathways may be responsible for PCSK9-induced endothelial dysfunction in sepsis. Vascular reactivity tests and survival studies showed that inhibition of PCSK9 could prevent the decrease in endothelium-dependent vasodilation function and improve the survival rates of septic mice. In summary, our results suggested that increased PCSK9 expression during sepsis activated the TLR4/MyD88/NF-κB and NLRP3 pathways to induce inflammation, which resulted in vascular endothelial dysfunction and decreased survival rates. Thus, inhibition of PCSK9 may be a potential clinical therapeutic target to improve vascular endothelial function in sepsis.
         datePublished:2022-08-05T00:00:00Z
         dateModified:2022-08-05T00:00:00Z
         pageStart:115
         pageEnd:128
         sameAs:https://doi.org/10.1007/s10753-022-01715-z
         keywords:
            PCSK9
            Sepsis
            Endothelial dysfunction
            Inflammation
            Immunology
            Rheumatology
            Pharmacology/Toxicology
            Pathology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig7_HTML.png
         isPartOf:
            name:Inflammation
            issn:
               1573-2576
               0360-3997
            volumeNumber:46
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Longxiang Huang
               url:http://orcid.org/0000-0002-7606-1235
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuanjing Li
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhe Cheng
               affiliation:
                     name:Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital
                     address:
                        name:Department of Cardiology, Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zi Lv
               affiliation:
                     name:Guangzhou Medical University
                     address:
                        name:Department of Obstetrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Suxin Luo
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Yong Xia
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
                     name:Davis Heart & Lung Research Institute, The Ohio State University College of Medicine
                     address:
                        name:Division of Cardiovascular Medicine, Davis Heart & Lung Research Institute, The Ohio State University College of Medicine, Columbus, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:PCSK9 Promotes Endothelial Dysfunction During Sepsis Via the TLR4/MyD88/NF-κB and NLRP3 Pathways
      description:Endothelial dysfunction often accompanies sepsis. We aimed to explore the role of PCSK9 in septic endothelial dysfunction. Sepsis was induced by lipopolysaccharide (LPS) treatment of human umbilical vein endothelial cells (HUVECs) in vitro and cecal ligation and puncture (CLP) surgery in mice in vivo. Evolocumab (EVC) and Pep 2–8, PCSK9 inhibitors, were subsequently used to determine the role of PCSK9 in sepsis-induced endothelial dysfunction in vitro and in vivo, respectively. In addition, the TLR4 agonist, Kdo2-Lipid A ammonium (KLA), was used to determine the related mechanism. Protein expression of eNOS, VE-cadherin, PCSK9, TLR4, MyD88, p-p65, p65, NLRP3, ASC, and caspase-1 p20 in mice aortas and HUVECs was measured by western blotting, while mRNA expression of TNFα, IL-1β, and IL-18 was determined by qRT-PCR. The level of inflammatory cytokines of mouse aortas was visualized by immunohistochemistry. Vasodilation of the aorta was detected by vascular reactivity experiments. The 96-h survival rate after CLP was assessed. Our findings showed that the expression of eNOS and VE-cadherin decreased, and PCSK9 expression increased, in septic HUVECs or mice. Inhibition of PCSK9 increased eNOS and VE-cadherin expression. Activation of the TLR4/MyD88/NF-κB and NLRP3 pathways may be responsible for PCSK9-induced endothelial dysfunction in sepsis. Vascular reactivity tests and survival studies showed that inhibition of PCSK9 could prevent the decrease in endothelium-dependent vasodilation function and improve the survival rates of septic mice. In summary, our results suggested that increased PCSK9 expression during sepsis activated the TLR4/MyD88/NF-κB and NLRP3 pathways to induce inflammation, which resulted in vascular endothelial dysfunction and decreased survival rates. Thus, inhibition of PCSK9 may be a potential clinical therapeutic target to improve vascular endothelial function in sepsis.
      datePublished:2022-08-05T00:00:00Z
      dateModified:2022-08-05T00:00:00Z
      pageStart:115
      pageEnd:128
      sameAs:https://doi.org/10.1007/s10753-022-01715-z
      keywords:
         PCSK9
         Sepsis
         Endothelial dysfunction
         Inflammation
         Immunology
         Rheumatology
         Pharmacology/Toxicology
         Pathology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01715-z/MediaObjects/10753_2022_1715_Fig7_HTML.png
      isPartOf:
         name:Inflammation
         issn:
            1573-2576
            0360-3997
         volumeNumber:46
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Longxiang Huang
            url:http://orcid.org/0000-0002-7606-1235
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuanjing Li
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhe Cheng
            affiliation:
                  name:Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital
                  address:
                     name:Department of Cardiology, Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zi Lv
            affiliation:
                  name:Guangzhou Medical University
                  address:
                     name:Department of Obstetrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Suxin Luo
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Yong Xia
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
                  name:Davis Heart & Lung Research Institute, The Ohio State University College of Medicine
                  address:
                     name:Division of Cardiovascular Medicine, Davis Heart & Lung Research Institute, The Ohio State University College of Medicine, Columbus, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Inflammation
      issn:
         1573-2576
         0360-3997
      volumeNumber:46
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital
      address:
         name:Department of Cardiology, Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital, Chongqing, China
         type:PostalAddress
      name:Guangzhou Medical University
      address:
         name:Department of Obstetrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
         type:PostalAddress
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Davis Heart & Lung Research Institute, The Ohio State University College of Medicine
      address:
         name:Division of Cardiovascular Medicine, Davis Heart & Lung Research Institute, The Ohio State University College of Medicine, Columbus, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Longxiang Huang
      url:http://orcid.org/0000-0002-7606-1235
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Yuanjing Li
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Zhe Cheng
      affiliation:
            name:Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital
            address:
               name:Department of Cardiology, Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Zi Lv
      affiliation:
            name:Guangzhou Medical University
            address:
               name:Department of Obstetrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Suxin Luo
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Yong Xia
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
            name:Davis Heart & Lung Research Institute, The Ohio State University College of Medicine
            address:
               name:Division of Cardiovascular Medicine, Davis Heart & Lung Research Institute, The Ohio State University College of Medicine, Columbus, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
      name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
      name:Department of Cardiology, Chongqing University, Three Gorges Hospital & Chongqing Three Gorges Central Hospital, Chongqing, China
      name:Department of Obstetrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
      name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
      name:Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
      name:Division of Cardiovascular Medicine, Davis Heart & Lung Research Institute, The Ohio State University College of Medicine, Columbus, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(166)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.92s.